CSPC PHARMACEUTICAL GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.63 HKD | -0.90% |
|
+3.76% | -8.68% |
| May. 30 | CSPC Pharmaceutical Repurchases 3 Million Shares | MT |
| May. 28 | CSPC Pharmaceutical Group Limited Announces Board Changes | CI |
| Sales 2024 * | 37.88B 4.84B | Sales 2025 * | 41.11B 5.26B | Capitalization | 78.53B 10.04B |
|---|---|---|---|---|---|
| Net income 2024 * | 7.15B 915M | Net income 2025 * | 7.72B 987M | EV / Sales 2024 * | 1.64 x |
| Net cash position 2024 * | 16.26B 2.08B | Net cash position 2025 * | 20.98B 2.68B | EV / Sales 2025 * | 1.4 x |
| P/E ratio 2024 * |
11
x | P/E ratio 2025 * |
10.2
x | Employees | 23,500 |
| Yield 2024 * |
3.2% | Yield 2025 * |
3.32% | Free-Float | 70.15% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -0.90% | ||
| 1 week | +3.76% | ||
| 1 month | +2.31% | ||
| 3 months | +8.33% | ||
| 6 months | -5.96% | ||
| Current year | -8.68% |
1 week
6.29
7.21
1 month
6.297.21
Current year
5.567.37
1 year
5.207.41
3 years
5.2012.68
5 years
5.2012.68
10 years
2.7713.93
| Managers | Title | Age | Since |
|---|---|---|---|
Cui Long Zhang
CEO | Chief Executive Officer | 55 | 95-12-31 |
Dong Chen Cai
CHM | Chairman | 70 | 97-12-31 |
Hao Jiang
BRD | Director/Board Member | 41 | 20-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 70 | 97-12-31 |
Wei Dong Pan
BRD | Director/Board Member | 55 | 05-12-31 |
Bo Wang
BRD | Director/Board Member | 64 | 12-12-20 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 4.05% | 2 M€ | -18.79% | - | |
| 2.02% | 4 M€ | -27.92% | ||
| 1.07% | 3 M€ | +0.10% | - | |
| 0.99% | 2 M€ | -14.14% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 6.63 | -2.93% | 119,789,700 |
| 24-05-30 | 6.83 | +1.19% | 54,740,500 |
| 24-05-29 | 6.75 | -3.98% | 50,557,890 |
| 24-05-28 | 7.03 | +2.03% | 74,673,760 |
| 24-05-27 | 6.89 | +7.82% | 77,876,120 |
Delayed Quote Hong Kong S.E., May 31, 2024 at 04:08 am EDT
More quotes
CSPC Pharmaceutical Group Ltd. specializes in the development, manufacture and marketing of pharmaceutical products. Net sames by category of products break down as follows:
- drugs (78.7%): innovative drugs (62.5% of sales) and common generic drugs (37.5%);
- vitamin C (10.1%);
- antibiotics (6.2%);
- other (5%): including anhydrous and raw caffeine.
Net sales are distributed geographically as follows: China (82.8%), Asia (7.2%), Europe (4.6%), the Americas (4.4%) and others (1%).
Sector
Pharmaceuticals
Calendar
2024-08-20
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
6.63
HKD
Average target price
9.584
HKD
Spread / Average Target
+44.55%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.68% | 10.04B | |
| +40.73% | 739B | |
| +32.83% | 598B | |
| -6.30% | 353B | |
| +15.15% | 318B | |
| +4.05% | 285B | |
| +15.00% | 240B | |
| +9.78% | 210B | |
| -5.52% | 206B | |
| +6.17% | 164B |
- Stock Market
- Equities
- 1093 Stock
